Mediassist Healthcare IPO GMP, Details, Guidance, Subscription Status, allotment @ Chanakyanipothi.com
    👉A legacy of 31 Years.
    India`s Oldest Investment & IPO website.
    👉Most Trusted by Investors across India.

    Table of Contents

    Post listing Review of Mediassist Healthcare IPO?   

    Listed at Rs. 450, at premium of 10.05% over the issue price. The listing has been below the expectations of the grey market.

    What is the last GMP of Mediassist Healthcare IPO?   
    Premium: Rs. 34 
    R- Subject to Rate   Rs. –
    H-Application Rate Rs. 900
    H-Subject to Rate   Rs.12600

    What are the promoters of Mediassist Healthcare IPO?   
    DR. VIKRAM JIT SINGH CHHATWAL, MEDIMATTER HEALTH MANAGEMENT PRIVATE LIMITED AND BESSEMER INDIA CAPITAL HOLDINGS II LTD are the promoters of the Mediassist Healthcare.

    What are the Objects of Mediassist Healthcare IPO?

    The Issue comprises only of Offer for sale.
    The objects of the Offer are to achieve the benefits of listing the Equity Shares on the Stock Exchanges and for the Offer for Sale

    Subscription Status of Mediassist Healthcare IPO?
    On 17 January 2024 5.00 pm (Day 3) (Closed)
    Review: subscription trend improved in last one hour.
    QIB:                5605634  Shares    40.14 T
    NII(10L+):      2802817  Shares    17.22 T
    NII (<10L)      1401409  Shares    10.12 T
    NII (Total)      4204226  Shares    14.85 T
    RII:                 9809859  Shares      3.19 T
    Total:           19619719   Shares   16.25 T

    What is the business of Mediassist Healthcare?

    Mediassist Healthcare is India’s largest health benefits administrator in terms of revenues in the Financial Years 2021, 2022 and 2023. Its primary clients are insurance companies; however, it also serves as an
    intermediary between (a) general and health insurance companies and the insured members, (b) insurance companies and healthcare providers (such as hospitals), and (c) the Government and beneficiaries of public health schemes. For the Financial Year 2022, its total revenues accounted for 24.89%, its EBITDA accounted for 40.88%, and its profit after tax accounted for 55.31%, of the Indian health benefits administration industry revenue, EBITDA and profit after tax, respectively.

    It is also the largest health benefits administrator in India in terms of premium under management for retail and group policies, with a market share of 14.83% of the retail health insurance market and 41.71% of the group health insurance market, and combined retail and group segment share of 33.67% serviced by health benefits administrators for the Financial Year 2022. It managed Rs.145,746.49 million of health insurance premiums (group and retail) as at the end of Financial Year 2023 growing at a CAGR of 35.67% from Rs.79,184.93 million as at the end of Financial Year 2021. As of March 31, 2023, we work with 36 insurance companies in India and globally.

    Its technology costs (operating costs and capital expenditure) were Rs.49.57 million, Rs.18.32 million and Rs.202.19 million for the Financial Years 2021, 2022 and 2023, respectively, and aggregated to 1.54%, 0.47% and 4.00% of its revenue from contracts with customers, respectively.
    It is the largest health benefits administrator in India in terms of premium under management for retail and group schemes. It serviced over 9,500 group accounts across sectors to help administer
    the insurance requirements of their employees. As of March 31, 2022, it managed around Rs.96 billion of group health insurance premiums, representing 26.01% of India’s overall group health insurance market and 41.71% of the group health insurance market serviced by health benefits administrators in Financial Year 2022. Its market share in the overall group health insurance market serviced by health insurance market serviced by health benefits administrators was nearly five times that of its nearest competitor in the Financial Year 2022

    For more information, click www.mediassist.in

    Mediassist Healthcare IPO GMP, Particulars & Guidance

    Mediassist Healthcare IPO Details 
    IPO opens on  15 January 2024 
    IPO closes on  17 January 2024 
    Issue Type Book Built Issue IPO
    Issue Size 28,028,168 Sh /Rs 1171.58 Cr
    * Fresh Issue – Sh /Rs – Cr
    * Offer for Sale  28,028,168 Sh /Rs 1171.58 Cr
       
    Face Value per share: Rs. 5
    Price Band  Rs. 397-418
    Retail Discount  Rs 0 per share
    Employee discount  Rs. 0 per share
    Retail Lot Size  35 Shares
    Listing will at  BSE, NSE
    Shares offered in Mediassist Healthcare? Shares Rs. in Cr
    QIB (50 %)  14014084 585.59
    NII (15 %)  4204225 175.74
    RII (35 %)  9809859 410.05
    Employees 
    Total Shares  28028168 1171.58
    Retail portion will be oversubscribed by  280281 Forms.
    How to apply in Mediassist Healthcare IPO ? Amount Rs.
    Min Retail Application     35 Sh     14630
    Max Retail Application    455 Sh   190190
    Small HNI (Min) application    490 Sh   204820
    Small HNI (Max) application 2380 Sh   994840
    Big HNI Application 2415 Sh 1009470

    What is the timetable of Mediassist Healthcare IPO?
    IPO opens on 15 January 2024
    IPO Closes on 17 January 2024
    IPO Allotment on  18 January2024
    Unblocking of ASBA  19 January 2024
    Credit of Shares 19 January 2024
    Listing on 22 January 2024
    Registered Office of Mediassist Healthcare
    Tower D, 4th floor, IBC Knowledge Park, 4/1 Bannerghatta Road, Bengaluru 560 029, Karnataka, India
    Who are the Lead Managers of Mediassist Healthcare IPO?
    Axis Capital Limited
    IIFL Securities Limited
    Nuvama Wealth Management Limited (formerly
    known as Edelweiss Securities Limited)
    SBI Capital Markets Limited
    Registrar to IPO
    Link Intime India Private Limited

    Mediassist Healthcare IPO Financial & Analytical Ratios
    Year Total Income Net Profit EPS RoNW
      Rs. in Cr Rs.in Cr Rs. %
    2020-21 345.57 38.00 5.67 12.99
    2021-22 412.02 63.47 9.22 18.71
    2022-23  518.95 75.31 10.94 19.63
    Book Value of the Share on 31.03.2023 Rs. 55.72    
    BV of the Share after the FPO Rs. ?    
    Offer Price at Cap Rs.  418    
    Mediassist Healthcare IPO
    Ratio Analysis
    Price /EPS 38.60
    Price/Book Value Ratio 7.50
    Price/BV after IPO  ?

    How Mediassist Healthcare IPO compares with the Peers?
    Peer Comparison.
    There are no listed companies in India that engage in a business similar to that of this Company and its Subsidiaries. Accordingly, it is not possible to provide an industry comparison in relation to this Company.

    As on date of DRHP FV Total  PE
      Rs. Income Ratio of
        Rs. In Cr  
           
           
           
           
           
           
           
           

    # This is only coverage of News related to Grey Market. We do not deal in grey market premium, nor we recommend dealing in Grey Market. Investment decision based on Grey Market trends can be faulty.

    Mediassist Healthcare IPO Guidance
    This is the much-awaited IPO. Mediassist Healthcare is India’s largest health benefits administrator in terms of revenues in the Financial Years 2021, 2022 and 2023. Its primary clients are insurance companies; however, it also serves as an intermediary between (a) general and health insurance companies and the insured members, (b) insurance companies and healthcare providers (such as hospitals), and (c) the Government and beneficiaries of public health schemes.
    As of March 31, 2022, it managed around Rs.96 billion of group health insurance premiums, representing 26.01% of India’s overall group health insurance market and 41.71% of the group health insurance market serviced by health benefits administrators in Financial Year 2022.
    The shares in this IPO are offered at very reasonable valuation of 38.60. The business has strong growth potential. Considering the growth potential and the valuation at which the shares are offered, we strongly recommend this IPO. Apply with FF (Full Force).

    Quicklinks

    Mediassist Healthcare IPO GMP

    Mediassist Healthcare IPO GMP today details

    Mediassist Healthcare IPO GMP today, Details, Guidance, Subscription Status, allotment

    Mediassist Healthcare IPO Anchor Investors details

    Medi Assist Healthcare Services IPO: Anchor investors buy Rs 351 crore of shares

    Medi Assist Healthcare Services, the Bengaluru-based health insurance third-party administrator, mobilised Rs 351.5 crore through its anchor book issue ahead of the IPO opening. The public issue will open next week on January 15 and will close on January 17.

    Marquee names in the list of anchor investors included Nomura Trust, Goldman Sachs, Ashoka Whiteoak, Pinebridge Global Funds, Troo Capital, and HSBC.

    Further, HDFC Mutual Fund, Kotak Mahindra Trustee, Aditya Birla Sun Life Trustee, SBI Life Insurance Company, Mirae Asset, Canara Robeco Mutual Fund, Tata Mutual Fund, Sundaram Mutual Fund, Bandhan Mutual Fund, Edelweiss Trusteeship, Bajaj Allianz Life Insurance Company, Max Life Insurance Company and SBI General Insurance Company among domestic investors also participated in the anchor book, which was launched for a day on January 12.

    The healthtech firm in consultation with the book-running lead managers has finalised the allocation of 84,08,449 equity shares to anchor investors at Rs 418 per share.

    16 Comments on “Mediassist IPO listed @ Rs.450

    1. Rita Keshwani, Mumbai

      Friends, I bought 500 shares of this IPO at premium of Rs. 80 and then at Rs. 64. My Average price is somewhere around Rs. 72. Will it go up again?

      Reply
    2. Saurabh Sen, Kolkatta

      HNI portion is very small and huge oversubscription expected. I feel, GMP will shoot up on 15th Jan.

      Reply
    3. Anamika Dalal, Rajkot

      Now I must follow this site without fail. Contributions of EagleEye and Mr irrelevant are very useful and profitable.

      Reply
    4. Shefali Pankaj Mumbai

      @Adminji,

      Is it true, the IPO obeservation, you give in IPO undercurrent is given by EagleEye?

      Congrats. I never knew EagleEye is active on this platform.

      Reply
    5. Amit Jhaveri, Mumbai

      Happy that EagleEye is now active on this site.

      I believe he is the main source of Premium news on this site. His expert guidance on Premium trend and oversubscription is valuable.

      Reply
    6. Anita Ram, New Delhi

      @ Vatsala,

      Agree with you fully. Must apply IPO. One more thing. one should sell on listing. Can fetch better profits in six months.

      Reply
    7. Vatsala Parikh, Vadodara

      One thing is crystal clear. This is offer for sale. Remember before few months, we had IPO of Protean Egov and it was also offer for sale. These are cash rich companies and they have excellent growth trends. So valuation is very cheap. One must accumulate at this premium from Grey market. Even buy on listing.

      Reply
    8. Upen Kinkhabwala, Ahmedabad

      @Utapalji,

      Do buy 100 shares of this IPO. Chances of huge oversubscription are high. and you will get good profits on listing.

      Reply
    9. Utpal Sheth, Pune

      Sanjana mam

      After long time, you have posted on this forum. You expert guidance on premium trends is appreciated. Should I buy 100 shares at current premium?

      Reply
    10. Sanjana Shah, Ahmedabad

      @Madhulika mam,

      Premium in grey market is very low. Suggest all Chanakya fans, not to sell at this rate. Solid uptrend expected.

      Reply
    11. Madhulika, Jodhpur

      Actually this small size IPO can provide excellent returns. I am going to apply with FF. I have 12 accounts in my Family. Not going to sell in premium market.

      Reply
    12. vanita Mehta, Mumbai

      Experts, can you explain business of this company? In simple words, I believe they are doing processing of mediclaims.
      Is it correct?

      Reply
    13. janki Vishal, Mumbai

      Another blockbuster IPO. I studied IPO guidance at Chanakya. Fully agree with them.
      I believe just like Protean Egov IPO, even this IPO will provide solid listing gains.
      Apply with FF (as Chanakya suggests)

      Reply

    Leave a Reply

    Your email address will not be published. Required fields are marked *